Type-II endometrial cancer: role of adipokines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Type-II endometrial cancer: role of adipokines

Published:2019-05-06 Issue:2 Volume:300 Page:239-249
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Garikapati Kusuma Kumari,Ammu V. V. V. Ravi Kiran,Krishnamurthy Praveen T.,Chintamaneni Pavan Kumar,Pindiprolu Sai Kiran S. S.

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00404-019-05181-1.pdf

Reference102 articles.

1. Reeves GK, Pirie K, Beral V et al (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134. https://doi.org/10.1136/bmj.39367.495995.AE

2. Schmandt RE, Iglesias DA, Co NN, Lu KH (2011) Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol 205:518–525. https://doi.org/10.1016/j.ajog.2011.05.042

3. Morice P, Leary A, Creutzberg C et al (2016) Endometrial cancer. Lancet 387:1094–1108. https://doi.org/10.1016/S0140-6736(15)00130-0

4. Saso S, Chatterjee J, Georgiou E et al (2011) Endometrial cancer. BMJ 343:d3954–d3954. https://doi.org/10.1136/bmj.d3954

5. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10–17

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Weight Loss on Key Obesity-Related Biomarkers Linked to the Risk of Endometrial Cancer: A Systematic Review and Meta-Analysis;Cancers;2024-06-11

2. Association of adipose tissue mediators with the development of cancer in patients with metabolic syndrome;Siberian journal of oncology;2024-05-12

3. Circulating Adipocytokines and Insulin Like-Growth Factors and Their Modulation in Obesity-Associated Endometrial Cancer;Cancers;2024-01-26

4. Obesity and metabolic syndrome as risk factors for endometrial cancer;Gazzetta Medica Italiana Archivio per le Scienze Mediche;2024-01

5. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling;International Journal of Molecular Sciences;2023-12-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3